Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 69680-161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 69680-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Memantine HCl Extended-release Capsules 14 mg (14mg)

Memantine HCl Extended-release Capsules 14 mg (14mg)
Each capsule of this medication contains 14 mg of memantine HCI. The usual dosage and other important information can be found in the package insert. It is important to keep this medication out of the reach of children and store it in a tightly closed container as per the instructions in the USP. The recommended storage temperature is 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The medication is manufactured by Xiamen LP Pharmaceutical Co., Ltd. in China and distributed by Viruvias Therapeutics in the USA. The product is an extended-release capsule formulation of memantine hydrochloride. The package contains 30 capsules. The information includes a unique identification number (GTIN), serial number (SN), expiration date (EXP), and lot number (LOT).*
FDA Label Image

Memantine HCl Extended-release Capsules 28 mg (28mg)

Memantine HCl Extended-release Capsules 28 mg (28mg)
Each capsule of this medication contains 28 mg of memantine hydrochloride. The recommended dosage can be found in the package insert. Keep the drug out of the reach of children and store it in a tightly closed container at a temperature of 25°C (77°F), with excursions permitted between 15-30°C (59-86°F). This drug is distributed by Vitruvias Therapeutics P LA and manufactured by Xiamen LP Pharmaceutical Co., Ltd in Xiamen, Fujian, China. It is an extended-release capsule for once-daily use. The package contains 30 capsules of 28mg each. The product is only available with a prescription. Additional information such as GTIN, SN, EXP, and LOT numbers are also provided.*
FDA Label Image

Memantine HCl Extended-release Capsules 7 mg (7mg)

Memantine HCl Extended-release Capsules 7 mg (7mg)
Each capsule of this medication contains 7 mg of memantine hydrochloride. The recommended storage temperature is 25°C (77°F), with permitted excursions between 15-30°C (59-86°F). Please refer to the package insert for full prescribing information, and keep this and all drugs out of the reach of children. The medication is supplied in a tightly closed container as described in the USP. It is manufactured by Xiamen LP Pharmaceutical Co., Ltd in China and distributed by Vitruvias Therapeutics in the USA. The product is an extended-release capsule, to be taken once daily. The expiration date indicated is MMYYYY, with the lot number XXXXXXXXX.*
FDA Label Image

Structure (Memantine001)

Structure (Memantine001)
FDA Label Image

Figure 1: Time Course Of The Change From Baseline In Sib Score For Patients Completing 24 Weeks Of Treatment. (Memantine002)

Figure 1: Time Course Of The Change From Baseline In Sib Score For Patients Completing 24 Weeks Of Treatment. (Memantine002)
FDA Label Image

Figure 2: Cumulative Percentage Of Patients Completing 24 Weeks Of Double-blind Treatment With Specified Changes From Baseline In Sib Scores. (Memantine003)

Figure 2: Cumulative Percentage Of Patients Completing 24 Weeks Of Double-blind Treatment With Specified Changes From Baseline In Sib Scores. (Memantine003)
FDA Label Image

Figure 3: Time Course Of The Cibic-plus Score For Patients Completing 24 Weeks Of Treatment. (Memantine004)

Figure 3: Time Course Of The Cibic-plus Score For Patients Completing 24 Weeks Of Treatment. (Memantine004)
FDA Label Image

Figure 4: Distribution Of Cibic-plus Ratings At Week 24. (Memantine005)

Figure 4: Distribution Of Cibic-plus Ratings At Week 24. (Memantine005)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.